(Q46542915)

English

Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus

scientific article published in March 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M E Garay-Sevilla

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

J C Regalado

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

J M Malacara

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

L E Nava

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

K Wróbel-Zasada

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

A Castro-Rivas

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

K Wróbel

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

28

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

223-230

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Diabetic neuropathy in elderly patients. What can be done?

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Diabetes and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Etiology and prognostic significance of albuminuria in diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Transforming growth factor beta contributes to progressive diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Renal catabolism of advanced glycation end products: the fate of pentosidine

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

1 reference

https://api.crossref.org/works/10.1007%2FBF03345377

21 January 2018

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in understanding mechanisms and natural history of diabetic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose and diabetic vascular disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycation end-products: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of the cross-link pentosidine in serum from normal and uremic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemical detection of advanced glycosylation end products in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycosylation end products and chronic complications of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15952406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03345377

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15952406

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46542915&oldid=2207939589"